Immune Design to Present at Upcoming Investment Conferences

SEATTLE and SOUTH SAN FRANCISCO, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced that Carlos Paya, M.D., Ph.D., President and Chief Executive Officer, will present at two investor conferences in March.

Cowen and Company 35th Annual Health Care Conference Tuesday, March 3, 2015 at 8:00 a.m. Eastern Time in Boston.

Barclays Global Healthcare Conference Thursday, March 12, 2015 at 1:35 p.m. Eastern Time, in Miami.

A live webcast of each presentation will be available online from the investor relations page of the company's corporate website at http://ir.immunedesign.com/events.cfm. After the live webcast, an archive of each presentation will be available on the company website.

About Immune Design

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body's immune system to fight disease. The company's technologies are engineered to activate the immune system's natural ability to generate and/or expand antigen-specific cytotoxic T cells, while enhancing other immune effectors, to fight cancer and other chronic diseases. Immune Design's three on-going immuno-oncology clinical programs are the product of its two synergistic discovery platforms, ZVexTM and GLAASTM. Immune Design has offices in Seattle and South San Francisco. For more information, visit www.immunedesign.com.

CONTACT: Media Contact
         Julie Rathbun
         Rathbun Communications
         [email protected]
         206-769-9219

         Investor Contact
         Robert H. Uhl
         Westwicke Partners
         [email protected]
         858-356-5932

You May Also Be Interested In

• BuyCryptoPressRelease.com Launches Specialized Crypto Press Release Distribution Platform for Blockchain and Web3 Projects 
• WISeKey Reports Unaudited Preliminary H1 2026 Key Metrics; Revenue Up 115%, FY 2026 Guidance Reaffirmed
• Advancing Neurological Disease Prediction through Machine Learning Techniques